Trials / Completed
CompletedNCT01793272
Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males
Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males With Mild and Moderate Asthenozoospermia: Randomized Controlled Prospective Crossover Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Adam International Hospital · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of pentoxifylline used in preparation of semen samples that will be used for ICSI in infertile men complaining of mild and moderate asthenozoospermia (i.e. cases which does not need motility enhancement prior to ICSI) in comparison to semen samples without pentoxifylline preparation on the outcome of ICSI.
Detailed description
The primary outcome measures were the number of oocytes retrieved, the number of oocytes injected, number of oocytes fertilized, fertilization rate, number of embryos and their quality (G1: good embryos, G2: fair embryos and G3: bad embryos), number of embryos transferred (ET), number of embryo sacs, embryo implantation rate, pregnancy rate and abortion rate for all 3 groups and pregnancy rate and abortion rate for both group (I) and group (II).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | effect of pentoxifylline on ICSI outcome | semen processing with pentoxifylline prior to ICSI |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-04-01
- Completion
- 2011-10-01
- First posted
- 2013-02-15
- Last updated
- 2013-02-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT01793272. Inclusion in this directory is not an endorsement.